This site uses cookies to store information on your computer. Learn more x

                                        Consensus Figures

                                        A number of international financial analysts cover DSM. The most recent consensus figures – provided by Vara Research – are detailed below. The figures are based on the estimates given by the banks that were approached by Vara Research.

                                        Analysts' consensus Q1 2019 and FY 2019 as at 15 April 2019

                                          Q1 2018 FY 2018 Q1 2019 E* FY 2019 E*
                                        Sales (continuing)        
                                        Number of Estimates     16 17
                                        Highest     2,486 9,564
                                        Consensus 2,435 9,267 2,297 9,331
                                        Median     2,273 9,343
                                        Lowest     2,229 9,010
                                        adj. EBITDA (continuing)        
                                        Number of Estimates     16 17
                                        Highest     409 1,727
                                        Consensus 538 1,822 397 1,665
                                        Median     394 1,660
                                        Lowest     383 1,629
                                        of which estimated adj. EBITDA from"Temporary Vitamin Effect"        
                                        Number of Estimates     11 12
                                        Highest     0 0
                                        Consensus 165 290 0 0
                                        Median     0 0
                                        Lowest     0 0
                                        Underlying business,  adj. EBITDA        
                                        Number of Estimates     16 17
                                        Highest     409 1,727
                                        Consensus 373 1,532 397 1,665
                                        Median     394 1,660
                                        Lowest     383 1,629
                                        adj. EBIT (continuing)        
                                        Number of Estimates     13 16
                                        Highest     280 1,189
                                        Consensus 423 1,345 268 1,140
                                        Median     265 1,139
                                        Lowest     259 1,091
                                        Nutrition, Sales        
                                        Number of Estimates     15 15
                                        Highest 1,650 6,137 1,699 6,385
                                        Consensus     1,514 6,148
                                        Median     1,495 6,136
                                        Lowest     1,448 5,906
                                        Nutrition, adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest 442 1,407 311 1,289
                                        Consensus     298 1,240
                                        Median     299 1,240
                                        Lowest     285 1,197
                                        of which adj. EBITDA from"Temporary Vitamin Effect"        
                                        Number of Estimates     11 11
                                        Highest 165 290 0 0
                                        Consensus     0 0
                                        Median     0 0
                                        Lowest     0 0
                                        Nutrition underlying,  adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest 277 1,117 311 1,289
                                        Consensus     298 1,240
                                        Median     299 1,240
                                        Lowest     285 1,197
                                        Nutrition, adj. EBIT        
                                        Number of Estimates     12 13
                                        Highest 370 1,111 233 969
                                        Consensus     219 915
                                        Median     219 915
                                        Lowest     210 863
                                        Materials, Sales        
                                        Number of Estimates     15 15
                                        Highest 738 2,913 766 3,042
                                        Consensus     735 2,960
                                        Median     738 2,965
                                        Lowest     701 2,876
                                        Materials, adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest 126 512 128 545
                                        Consensus     123 518
                                        Median     125 516
                                        Lowest     117 501
                                        Materials, adj. EBIT        
                                        Number of Estimates     12 13
                                        Highest 95 383 96 428
                                        Consensus     89 380
                                        Median     90 379
                                        Lowest     79 331
                                        Innovation Center, Sales        
                                        Number of Estimates     15 15
                                        Highest 36 172 47 191
                                        Consensus     40 181
                                        Median     39 180
                                        Lowest     36 172
                                        Innovation Center, adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest -1 8 5 32
                                        Consensus     2 14
                                        Median     3 13
                                        Lowest     -1 5
                                        Innovation Center, adj. EBIT        
                                        Number of Estimates     12 13
                                        Highest -6 -14 -2 -9
                                        Consensus     -4 -14
                                        Median     -4 -11
                                        Lowest     -9 -32
                                        Corporate Activities, Sales        
                                        Number of Estimates     15 15
                                        Highest 11 45 18 70
                                        Consensus     12 48
                                        Median     11 46
                                        Lowest     10 45
                                        Corporate Activities, adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest -29 -105 -25 -95
                                        Consensus     -27 -106
                                        Median     -27 -106
                                        Lowest     -29 -110
                                        Corporate Activities, adj. EBIT        
                                        Number of Estimates     12 13
                                        Highest -36 -135 -32 -133
                                        Consensus     -35 -138
                                        Median     -35 -138
                                        Lowest     -37 -145
                                        Profit for the period, before exceptional items - Cont. Ops.        
                                        Number of Estimates     12 14
                                        Highest 337 1,034 217 923
                                        Consensus     204 863
                                        Median     205 865
                                        Lowest     191 813
                                        Net EPS before exceptional items - Cont. Ops.        
                                        Number of Estimates     12 14
                                        Highest 1.91 5.84 1.25 5.30
                                        Consensus     1.16 5.00
                                        Median     1.16 5.00
                                        Lowest   0.72 1.08 4.71

                                        * Analysts were asked by Vara Research to include the estimated IFRS16 effect in the DSM consensus poll for 2019 Q1 and FY 2019.
                                         

                                        Related links

                                        Disclaimer
                                        Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.

                                        吉林快三开奖走势图